Tactile Systems Technology, Inc.
NGM: TCMDLive Quote
📈 ZcoreAI Score
Our AI model analyzes Tactile Systems Technology, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get TCMD Z-Score →About Tactile Systems Technology, Inc.
Healthcare
Medical Devices
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
📊 Fundamental Analysis
Tactile Systems Technology, Inc. demonstrates a profit margin of 5.8%, which is below the sector average, suggesting competitive pressure.
The company recently reported 21.0% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is 8.8%, which suggests room for improvement in capital utilization.
At a current price of $23.43, TCMD currently sits at the 51st percentile of its 52-week range (Range: $8.61 - $37.77).
💰 Valuation Insight
TCMD is valued broadly in line with the sector at a PE of 28.57. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$533.04M
Trailing P/E
28.57
Forward P/E
15.83
Beta (5Y)
0.99
52W High
$37.77
52W Low
$8.61
Avg Volume
329K
Day High
Day Low